Encephalopathy future or investigational therapies

Jump to navigation Jump to search

Encephalopathy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Encephalopathy from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Electroencephalogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Encephalopathy future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Encephalopathy future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Encephalopathy future or investigational therapies

CDC on Encephalopathy future or investigational therapies

Encephalopathy future or investigational therapies in the news

Blogs on Encephalopathy future or investigational therapies

Directions to Hospitals Treating Encephalopathy

Risk calculators and risk factors for Encephalopathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Newer investigational and therapeutic modalities are under consideration.

New Therapies

Newer modalities of treatment are considered for hypoxic encephalopathy. These drugs reduce the brain activity and its oxygen requirements.

References

Template:WH Template:WS